Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes

Abstract

Bone marrow samples from 30 patients with myelodysplastic syndromes (MDS) grouped according to the International Prognostic Scoring System for MDS were investigated for counts of microvessels, total metachromatic mast cells (MC) and MC expressing tryptase, an angiogenesis-inducing molecule. Counts were higher in patients with a poor prognosis. The observation of a high correlation between microvessel counts and both total metachromatic and tryptase-reactive MC in all samples suggests that angiogenesis in MDS increases with their progression and that MC may intervene in the angiogenic response in MDS through tryptase contained in their secretory granules.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Folkman J . What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1989 82: 4–6

    Article  Google Scholar 

  2. Folkman J . Angiogenesis dependent diseases Semin Oncol 2001 28: 536–542

    Article  CAS  Google Scholar 

  3. Vacca A, Ribatti D, Roncali L, Ranieri G, Serio G, Silvestris F, Dammacco F . Bone marrow angiogenesis and progression in multiple myeloma Br J Haematol 1994 87: 503–508

    Article  CAS  Google Scholar 

  4. Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R, Albini A, Bussolino F, Dammacco F . Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma Blood 1999 93: 3064–3073

    CAS  Google Scholar 

  5. Pruneri G, Bertolini F, Soligo D, Carboni N, Cortellezzi A, Ferrucci PF, Buffa R, Lambertenghi-Deliliers G, Pezzella F . Angiogenesis in myelodysplastic syndromes Br J Cancer 1999 81: 1398–1401

    Article  CAS  Google Scholar 

  6. Aguayo A, Kantarjian H, Manshouri T, Gidel C, Estey E, Yhomas D, Koller C, Estrov Z, O'Brien S, Keating M, Freireich E, Albitar M . Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Blood 2000 96: 2240–2245

    CAS  Google Scholar 

  7. Korkolopoulou P, Apostolidou E, Pavlapoulos PM, Kavantzas N, Vyniou N, Thymarai I, Terpos E, Patsouris E, Yataganas X, Davaris P . Prognostic evaluation of the microvascular network in myelodysplastic syndromes Leukemia 2001 15: 1369–1376

    Article  CAS  Google Scholar 

  8. Park CC, Bissell MJ, Barcellos-Hoff MH . The influence of the microenvironment on the malignant phenotype Mol Med Today 2000 6: 324–329

    Article  CAS  Google Scholar 

  9. Ribatti D, Vacca A, Nico B, Crivellato E, Roncali L, Dammacco F . The role of mast cells in tumour angiogenesis Br J Haematol 2001 115: 514–521

    Article  CAS  Google Scholar 

  10. Ribatti D, Nico B, Vacca A, Marzullo A, Calvi N, Roncali L, Dammacco F . Do mast cells help to induce angiogenesis in B-cell non-Hodgkin's lymphomas? Br J Cancer 1998 77: 1900–1906

    Article  CAS  Google Scholar 

  11. Ribatti D, Vacca A, Nico B, Quondamatteo F, Ria R, Minischetti M, Marzullo A, Herken R, Roncali L, Dammacco F . Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma Br J Cancer 1999 79: 451–455

    Article  CAS  Google Scholar 

  12. Ribatti D, Vacca A, Marzullo A, Nico B, Ria R, Roncali L, Dammacco F . Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas Int J Cancer 2000 85: 171–175

    Article  CAS  Google Scholar 

  13. Greenberg P, Cox C, Le Beau MM, Feneaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiri K, Toyama K, Aul C, Mufti G, Bennett J . International scoring system for evaluating prognosis in myelodysplastic syndromes Blood 1997 89: 2079–2088

    CAS  Google Scholar 

  14. Vacca A, Ribatti D, Roncali L, Lospalluti M, Serio G, Carrel S, Dammacco F . Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor Cancer 1993 72: 455–461

    Article  CAS  Google Scholar 

  15. Ribatti D, Roncali L, Nico B, Bertossi M . Effects of exogenous heparin on the vasculogenesis of the chorioallantoic membrane Acta Anat 1987 130: 257–263

    Article  CAS  Google Scholar 

  16. Sorbo J, Jakobbson A, Norrby K . Mast cell histamine is angiogenic through receptors for histamine 1 and histamine 2 Int J Exp Pathol 1994 75: 43–50

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Moller A, Henz BM, Grutzkau A, Lippert U, Aragane Y, Schwarz T, Kruger-Krasagakes S . Comparative cytokine gene expression: regulation and release by human mast cells Immunology 1998 93: 289–295

    Article  CAS  Google Scholar 

  18. Grutzkau A, Kruger-Krasagakes S, Kogel H, Moller A, Lippert U, Henz BM . Detection of intracellular interleukin-8 in human mast cells: flow cytometry as a guide for immunoelectron microscopy J Histochem Cytochem 1997 45: 935–945

    Article  CAS  Google Scholar 

  19. Qu Z, Leibler JM, Powers MR, Galey T, Ahmadi P, Huang XN, Ansel JC, Butterfield JH, Planck SR, Rosembaum JT . Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma Am J Pathol 1995 147: 546–547

    Google Scholar 

  20. Grutzkau A, Kruger-Krasagakes S, Baumesteir H, Schwarz C, Kogel H, Welker P, Lippert U, Henz BM, Moller A . Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF 206 Mol Biol Cell 1998 9: 875–884

    Article  CAS  Google Scholar 

  21. Blair RJ, Meng H, Marchese MJ, Ren S, Schwartz LB, Tonnesen MG, Gruber BL . Human mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor J Clin Invest 1997 99: 2691–2700

    Article  CAS  Google Scholar 

  22. Stack MS, Johnson DA . Human mast cell tryptase activates single-chain urinary-type plasminogen activator (pro-urokinase) J Biol Chem 1994 269: 9416–9419

    CAS  PubMed  Google Scholar 

  23. Mignatti P, Rifkin DB . Biology and biochemistry of proteinases in tumor invasion Physiol Rev 1993 73: 161–195

    Article  CAS  Google Scholar 

  24. Bellamy WT, Richter L, Sirjani D, Roxas C, Glinsmann-Gibson B, Frutiger Y, Grogan TM, List AF . Vascular endothelial growth factor is an autocrine promoter of abnormal localized immature myeloid precursors and leukemia progenitor formation in myelodysplastic syndromes Blood 2001 97: 1427–1434

    Article  CAS  Google Scholar 

  25. Duncan LM, Richards LA, Mihm MC . Increased mast cell density in invasive melanoma J Cutan Pathol 1998 25: 11–15

    Article  CAS  Google Scholar 

  26. Toth T, Toth-Jakatics R, Jimi S, Takebayashi S, Kawamoto N . Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor Hum Pathol 2000 31: 955–960

    Article  Google Scholar 

  27. Saskela O, Moscatelli D, Rifkin DB . The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells J Cell Biol 1987 105: 957–963

    Article  Google Scholar 

  28. Shih IM, Herlyn M . Autocrine and paracrine roles for growth factors in melanoma In Vivo 1994 8: 113–124

    CAS  PubMed  Google Scholar 

  29. Akimoto S, Ishikaw O, Iijima C, Miyachi Y . Expression of basic fibroblast growth factor and its receptor by fibroblasts, macrophages and mast cells in hypertrophic scar Eur J Dermatol 1999 9: 357–362

    CAS  PubMed  Google Scholar 

  30. Ribatti D, Contino R, Tursi A . Do mast cells intervene in the vasoproliferative processes of the rheumatoid synovitis? J Sumbicrosc Cytol Pathol 1988 20: 635–637

    CAS  Google Scholar 

  31. Singhal S, Metha J, Desikan R, Ayers D, Robertson P, Eddlemon P, Munshi N, Anaissie E, Wilson C, Dhodapkar M, Zeddis J, Barlogie B . Antitumor activity of thalidomide in refractory multiple myeloma New Engl J Med 1999 341: 1567–1571

    Article  Google Scholar 

  32. Raza A, Meyer P, Dutt D, Zorat F, Lisak L, Nascimben F, Durandt M, Kaspar C, Goldberg C, Loew J, Dar S, Gezer S, Venugopal P, Zeldis J . Thalidomide produces transfusion independence in long-stading refractory anemias in patients with myelodysplastic syndromes Blood 2001 98: 958–965

    Article  CAS  Google Scholar 

  33. Richardson P, Hideshima T, Anderson K . Thalidomide: emerging role in cancer medicine Ann Rev Med 2002 53: 629–657

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported in part by grants from Associazione Italiana per la Ricerca sul Cancro, Milan, and Associazione Italiana per la Lotta al Neuroblastoma, Genoa, Italy.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ribatti, D., Polimeno, G., Vacca, A. et al. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes. Leukemia 16, 1680–1684 (2002). https://doi.org/10.1038/sj.leu.2402586

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2402586

Keywords

This article is cited by

Search

Quick links